| Cash Flow | 2025-06-30 |
|---|---|
| Net loss from continuing operations | -9,150 |
| Stock-based compensation expense | 1,029 |
| Amortization on operating lease right-of-use assets | 210 |
| Prepaid expenses and other current assets | 803 |
| Other liabilities | -350 |
| Other assets | 0 |
| Lease liabilities | -29 |
| Inventory | -313 |
| Deferred revenue | -410 |
| Deferred tax asset | 0 |
| Income tax payable | -613 |
| Accounts receivable | 28 |
| Accounts payable and accrued expenses | 448 |
| Debt extinguishment loss | -718 |
| Loss from lease termination | -1,357 |
| Loss (gain) from disposal of fixed assets | -868 |
| Change in fair value of warrant liability | 40 |
| Depreciation and amortization | 2,831 |
| Realized loss on marketable debt securities | 0 |
| Amortization of debt discount | 849 |
| Employee retention tax credit income | 1,549 |
| Inventory reserve | 0 |
| Deferred tax liability | 0 |
| Accrued diagnostic services | 44 |
| Accrued advertising and other allowances | 0 |
| Net cash used in operating activities - continuing operations | -4,225 |
| Net cash provided by (used in) operating activities - discontinued operations | 597 |
| Net cash used in operating activities | -3,628 |
| Proceeds from sales of fixed assets | 120 |
| Proceeds from sales of marketable securities | 0 |
| Capital expenditures | 0 |
| Net cash provided by investing activities - continuing operations | 120 |
| Net cash provided by (used in) investing activities - discontinued operations | 800 |
| Net cash provided by investing activities | 920 |
| Repayment of note payable | 2,511 |
| Proceeds from issuance of note payable to related party, net | 500 |
| Proceeds from issuance of note payable, net | 687 |
| Proceeds from issuance of common shares, net | 3,558 |
| Net cash provided by financing activities - continuing operations | 2,234 |
| Net cash used in financing activities - discontinued operations | -35 |
| Net cash provided by financing activities | 2,199 |
| Decrease in cash and cash equivalents | -509 |
ProPhase Labs, Inc. (PRPH)
ProPhase Labs, Inc. (PRPH)